Recruiting

Implanet Jazz

Sponsor:

Francis Farhadi

Code:

NCT05366140

Conditions

Spondylolisthesis

Spinal Stenosis

Degenerative Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Prospective follow-up of patients who have received instrumented lumbar arthrodesis supplemented the Implanet Jazz System(TM)

Study Details

Brief summary:

Establish a data repository of patients who have undergone single, two-, or three-level lumbar instrumented arthrodesis procedures supplemented by the Implanet Jazz System.

Conditions

Spondylolisthesis

Spinal Stenosis

Degenerative Disease

Study ID

NCT05366140

Start date

Feb 3, 2022

Status verified date

Oct, 2025

Completion date

Sep, 2028

Anticipated

Primary completion date

Sep, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Male and female patients, 18 years of age and older
  • Qualified candidate for hybrid thoracolumbar fixation with the Implanet Jazz System TM during arthrodesis surgery.

Exclusion Criteria:

  • Individuals who have not yet reached the age of 18.

Study Design

Enrollment

300 participants

Anticipated

Interventions and Outcome Measures

Interventions

Prospective follow-up of patients who have received instrumented lumbar arthrodesis supplemented the Implanet Jazz System(TM)

To assess the clinical outcomes of patients receiving standard of care Implanet Jazz System(TM) at the time of their instrumented lumbar arthrodesis.

Primary outcome measure

  • clinical prospective review- Prospective Database study for future studies [ Time Frame: 5- years ]

Central Contacts and Locations

Central contacts

Locations

University of Kentucky

Recruiting

Lexington, Kentucky, United States, 40536

Contacts

More Information

Sponsor

Francis Farhadi

Last update posted

Oct 27, 2025

Last verified

Oct, 2025

Keywords

  • Thoracic-Lumbar Arthrodesis
  • Spinal fusion
  • back pain

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Francis Farhadi on 2025-10-27.